Abstract
BackgroundIn patients with ST-elevation myocardial infarction (STEMI), urinary tract infection is the most common infection-related complication. Prostatic abscess in a patient with STEMI is very rare.Case presentationWe report the case of a 49-year-old Japanese man who developed fever and shaking chills during hospitalization for STEMI. We initially diagnosed catheter-associated urinary tract infection. However, subsequent contrast-enhanced computed tomography revealed multiple large abscesses in his prostate. We decided to treat with antimicrobial agents alone because the patient was receiving dual-antiplatelet therapy and discontinuation is very high risk for in-stent thrombosis. The patient recovered remarkably after treatment without drainage or surgery.ConclusionsHere, we described the world’s first reported case of prostatic abscess in an immunocompetent patient with STEMI. Early removal of indwelling bladder catheters in patients with STEMI receiving dual-antiplatelet therapy is important to avoid development of prostatic abscess. Furthermore, unnecessary invasive instrumentation should be avoided or limited to diminish the risk of infections.
Highlights
In patients with ST-elevation myocardial infarction (STEMI), urinary tract infection is the most common infection-related complication
Here, we described the world’s first reported case of prostatic abscess in an immunocompetent patient with STEMI
The infection-related complication rate in patients hospitalized for ST-elevation myocardial infarction (STEMI) has been reported to be 16.6 % [1]
Summary
We described the world’s first reported case of prostatic abscess in an immunocompetent patient STEMI. Such patients usually have a higher risk with drainage due to receiving dual-antiplatelet therapy. A copy of the written consent is available for review by the Editor of this journal. Competing interests Both authors have no financial interests to disclose and no competing interest to declare. Authors’ contributions YK: Clinical management of the case, manuscript redaction and correction. Both authors read and approved the final manuscript
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.